Combined methods for treating a patient using time-varying magnetic field are described. The treatment methods combine various approaches for aesthetic treatment. The methods are focused on enhancing a visual appearance of the patient.

The present disclosure provides a combined Pulsed Electromagnetic Field (PEMF) therapy and Photobiomodulation (PBM) therapeutic device in the form of a flexible wearable that can be secured to a user's body part to apply targeted radiation to a desired area. The frequencies and pulse patterns of both types of radiation are controlled by a single controller of the device which can switch between a number of pre-set sequences and patterns. The device is wirelessly enabled to allow control via an external user device.

The present invention provides a non-drug cardio-cerebrovascular disease therapeutic apparatus. A waveform diagram of a pulse current for generating a pulse electromagnetic field includes four characteristic bands in a cycle range of 360° and reciprocates circularly: an abrupt-rising band T1 where a current intensity I(t) abruptly rises, wherein a highest value thereof is slightly lower than a maximum value Imax of an output current; a first slow-rising band T2 where the current intensity I(t) slowly rises to the maximum value Imax; an abrupt-decreasing band T3 where the current intensity I(t) abruptly decreases, wherein a minimum value Imin thereof is slightly higher than a minimum value (Imin) of the output current; and a slow-decreasing band T4 where the current intensity I(t) slowly decreases to the minimum value (Imin). The non-drug cardio-cerebrovascular disease therapeutic apparatus provided by the present invention can significantly improve and treat cardio-cerebrovascular diseases and achieve obvious effects.

The present invention provides a non-drug cardio-cerebrovascular disease therapeutic apparatus. A waveform diagram of a pulse current for generating a pulse electromagnetic field includes four characteristic bands in a cycle range of 360° and reciprocates circularly: an abrupt-rising band T1 where a current intensity I(t) abruptly rises, wherein a highest value thereof is slightly lower than a maximum value Imax of an output current; a first slow-rising band T2 where the current intensity I(t) slowly rises to the maximum value Imax; an abrupt-decreasing band T3 where the current intensity I(t) abruptly decreases, wherein a minimum value Imin thereof is slightly higher than a minimum value (Imin) of the output current; and a slow-decreasing band T4 where the current intensity I(t) slowly decreases to the minimum value (Imin). The non-drug cardio-cerebrovascular disease therapeutic apparatus provided by the present invention can significantly improve and treat cardio-cerebrovascular diseases and achieve obvious effects.

A magnetic stimulation probe is provided to produce a probe electromagnetic field within a patient. The magnetic stimulation probe has a first generally planar magnetic field generating coil having a first coil trace having a decreasing radial spiral which passes about a first central portion, the first coil trace having a first electric current traveling in a first direction and having a first plurality of separated portions each having a first respective set of different radii from the first central portion along a bisecting line. The first planar coil has a second coil trace having a second electric current traveling in a second direction which is parallel to the first direction, and having a second plurality of separated portions each having a second respective set of different radii from the first central portion along the bisecting line along the bisecting line. Two such coils can be arranged to produce a high intensity focused magnetic field at a distance from the probe. The probe electromagnetic field is operable to induce a current in a conductive material.

A magnetic stimulation probe is provided to produce a probe electromagnetic field within a patient. The magnetic stimulation probe has a first generally planar magnetic field generating coil having a first coil trace having a decreasing radial spiral which passes about a first central portion, the first coil trace having a first electric current traveling in a first direction and having a first plurality of separated portions each having a first respective set of different radii from the first central portion along a bisecting line. The first planar coil has a second coil trace having a second electric current traveling in a second direction which is parallel to the first direction, and having a second plurality of separated portions each having a second respective set of different radii from the first central portion along the bisecting line along the bisecting line. Two such coils can be arranged to produce a high intensity focused magnetic field at a distance from the probe. The probe electromagnetic field is operable to induce a current in a conductive material.

Proposed are a device for supporting height growth by using a pulsed micro-electromagnetic field, and a method for driving the device. According to an embodiment, the device may include an antenna band part including a first antenna and a second antenna which are provided inside a covering part that is configured to surround a joint and which are configured to generate a micro-magnetic field at the joint in a contactless manner, and may include a control unit configured to generate the micro-magnetic field by forming a high frequency voltage and providing the high frequency voltage to the antenna band part, the control unit being configured to adjust the formed high frequency voltage, on the basis of a sensing value of a micro-electromagnetic field sensed at the second antenna, such that a micro-magnetic field corresponding to a diameter of the joint is provided.

Proposed are a device for supporting height growth by using a pulsed micro-electromagnetic field, and a method for driving the device. According to an embodiment, the device may include an antenna band part including a first antenna and a second antenna which are provided inside a covering part that is configured to surround a joint and which are configured to generate a micro-magnetic field at the joint in a contactless manner, and may include a control unit configured to generate the micro-magnetic field by forming a high frequency voltage and providing the high frequency voltage to the antenna band part, the control unit being configured to adjust the formed high frequency voltage, on the basis of a sensing value of a micro-electromagnetic field sensed at the second antenna, such that a micro-magnetic field corresponding to a diameter of the joint is provided.

A cell destruction method includes providing an anionic biomarker that comprises a magnetic material such as an iron or an iron compound. The anionic biomarker is introduced into an organism having pathogen cells with a negative charge. The anionic biomarkers are attracted to the negative charges of the pathogen and couple thereto. The anionic biomarker may also have a coupler portion that further aids in the anionic biomarker coupling to and being bound to the pathogen cell and/or cell wall. An electric field may be produced to cause the anionic biomarkers and/or the negative charges of the pathogen cell to polarize on or along the pathogen cell. A magnetic field is directed to cause the anionic biomarker, or magnetic material thereof to move and damage the cell. The magnetic field may be an alternating magnetic field that causes the magnetic material to oscillate and damage the cell wall.

A neurostimulation system is disclosed for providing treatment to a patient during a therapy session. The neurostimulation system includes a neurostimulator for transmitting magnetic or electrical signals based upon a treatment program. A programmer is connected to the neurostimulator to set a treatment session parameter value to calculate a therapy compliance value. A compliance module is connected to the neurostimulator and the programmer to calculate and store a therapy compliance value. A control module is connected to the compliance module, the programmer and the neurostimulator and determines whether the therapy compliance value is within a range of the treatment program. The neurostimulator transmits electrical or magnetic signals to the patient in a treatment session only if the therapy compliance value meets a compliance criteria.